EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis

Hans-Peter Hartung, Derrick Robertson, Lawrence Steinman, Douglas L Arnold, Peiqing Qian, Sibyl Wray, Edward Fox, Christopher A Garner, Yihuan Xu, Koby Mok, Anne Gocke, Bruce A C Cree und 1 weitere

Neurology and Therapy · 2026-06 · 15 (3) · 1081-1097

DOI: 10.1007/s40120-026-00904-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology and Therapy, online erschienen am 06.03.2026. Verfasst von Hans-Peter Hartung und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany. hans-peter.hartung@uni-du…. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: TG Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Annualized relapse rateAnti-CD20Highly active diseaseMultiple sclerosisNo evidence of disease activityRadiologic diseaseUblituximab

Autor:innen und Institutionen

  • Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany. hans-peter.hartung@uni-duesseldorf.de.
  • Brain and Mind Centre, University of Sydney, Sydney, Australia. hans-peter.hartung@uni-duesseldorf.de.
  • Medical University of Vienna, Vienna, Austria. hans-peter.hartung@uni-duesseldorf.de.
  • Palacký University Olomouc, Olomouc, Czech Republic. hans-peter.hartung@uni-duesseldorf.de.
  • University of South Florida, Tampa, FL, USA.
  • Stanford University, Stanford, CA, USA.

Förderung

  • TG Therapeutics

Zitieren

APA

Hartung, H. P., Robertson, D., Steinman, L., Arnold, D. L., Qian, P., Wray, S., Fox, E., Garner, C. A., Xu, Y., Mok, K., Gocke, A., Cree, B. A. C., & Alvarez, E. (2026). Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis. Neurology and Therapy, 15(3), 1081-1097. https://doi.org/10.1007/s40120-026-00904-4

Vancouver

Hartung HP, Robertson D, Steinman L, Arnold DL, Qian P, Wray S, et al. Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis. Neurology and Therapy. 2026;15(3):1081-1097. doi:10.1007/s40120-026-00904-4

BibTeX
@article{Hartung2026,
  author = {Hartung, Hans-Peter and Robertson, Derrick and Steinman, Lawrence and Arnold, Douglas L and Qian, Peiqing and Wray, Sibyl and Fox, Edward and Garner, Christopher A and Xu, Yihuan and Mok, Koby and Gocke, Anne and Cree, Bruce A C and Alvarez, Enrique},
  title = {Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis},
  journal = {Neurology and Therapy},
  year = {2026},
  volume = {15},
  number = {3},
  pages = {1081--1097},
  doi = {10.1007/s40120-026-00904-4}
}
Kostenlos starten →